Overview

Adjunctive Clonidine in the Sedation of Mechanically Ventilated Children

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
0
Participant gender:
All
Summary
Almost all critically ill children who are mechanically ventilated require sedation and analgesia. Providing effective sedation for children in the PICU requires careful balancing of the need for sedation with the adverse effects associated with sedative medications. Clonidine is often used as an adjunctive sedative and analgesic in children but a well designed and adequately powered randomized trial is required to test the effect of clonidine-based sedation. Because there are no large randomized trials of sedation related interventions among critically ill children there are many unknown factors. This pilot trial, focussing on feasibility outcomes will assess the feasibility of, and inform the design of, a larger randomized controlled trial which will focus on clinically important outcomes.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hamilton Health Sciences Corporation
Collaborator:
McMaster University
Treatments:
Clonidine
Criteria
Inclusion Criteria:

- aged 1 month to 18 years

- mechanically ventilated

- the attending physician expects to require mechanical ventilation for at least 2 more
days

- requires sedation in the form of: morphine by continuous infusion or greater than 4
intermittent doses in the previous 24 hours or fentanyl as a continuous infusion AND
midazolam or lorazepam by continuous infusion or more than 3 intermittent doses of
lorazepam or 6 doses of midazolam in the previous 12 hours

- has enteral access (gastric or jejunal feeding tube)

Exclusion Criteria:

- hemodynamically unstable

- meet the American College of Critical Care Medicine hemodynamic definition of shock

- hypotensive or tachycardic

- bradycardia, hemodynamically significant cardiac disease or chronic use of
anti-hypertensive or diuretic medications

- a traumatic brain injury on admission

- chronically (defined as routine administration prior to hospital admission or for
greater than 7 days in hospital prior to PICU admission) use benzodiazepines or
opioids

- have received greater than two doses of clonidine within the previous 2 days or
dexmedetomidine in the past 2 days

- were previously enrolled in this study

- are currently enrolled in a related study

- are known to be pregnant or breastfeeding

- are known to be allergic to clonidine or any other ingredient in the tablets or
suspension

- are being considered for organ procurement

- were chronically (>30 days) ventilated prior to PICU admission

- are currently receiving, or are expected to initiate the ketogenic diet

- are receiving cyclosporine or methylphenidate